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Hallucination research is undergoing major changes. The 
sharing of knowledge, techniques, data, and resources 
together with the cross-pollination of ideas and inspi-
ration hold promises of new breakthroughs and clinical 
discoveries for people who are experiencing distressing 
voices, visions, and related symptoms.
The articles in this special supplement of Schizophrenia 
Bulletin comprise the reports of 7 working groups who 
presented at the recent meeting of the International 
Consortium on Hallucination Research and Related 
Symptoms (ICHR). ICHR is a multidisciplinary initia-
tive that brings together a balance of researchers, clini-
cians, voice-hearers, and decision makers to enhance our 
understanding of hallucinations in its various manifes-
tations. In the past 7 years, and building on knowledge 
gained from each meeting,1–3 collaborative activities 
among ICHR attendees have made a practical difference 
in the development of translational research, fostering of 
dynamic and productive relationships, progress toward 
genuine engagement with voice hearers and consumer 
organizations, and building of capacity through student 
exchange and multicenter initiatives.
On November 6–8, 2017, the fourth biannual meet-
ing of the ICHR took place in Lille, France, hosted by 
R.J.  and F.L. It was attended by 225 participants from 
18 countries. Through guided activities, working-group 
presentations, and group discussions (see full program at 
ichr2017.sciencesconf.org), a range of issues, challenges, 
and difficulties were discussed. Voices, visions, and 
related symptoms are extremely difficult to understand, 
and there was a consensus for the continued importance 
of mixed approaches and multiple perspectives to secure 
the best possible outcomes.
In the preparation for the Lille meeting and this sup-
plement, we were guided by the recommendations from 
previous meetings, emerging topics, and new proposals. 
There were 19 oral presentations and 33 posters. Major 
themes were as follows:
• Interventions and self-help groups (with a “living sculp-
tures” workshop from Ron Coleman and Karen Taylor 
and a prize-winning poster from Mark Hayward on the 
Sussex Voices Clinic, United Kingdom);
• Neurodevelopmental and maturational perspectives 
(with presentations from Agna Bartels, Kim Maijer, 
and Iris Sommer, the Netherlands);
• Trauma (Tanya Luhrmann, United States; F.W., 
Australia; Craig Steel, United Kingdom; Simon 
McCarthy-Jones, Ireland);
• Digital technologies in hallucination assessment, treat-
ment, and self-help (Neil Thomas, Australia; R.J., 
France; Josef Bless, Norway; David van den Berg, the 
Netherlands);
• Neurobiological processes (Andrei Arkhipov and 
Maslennikova, Russia; Judith Ford, United States; 
Susan Rossell and Matthew Hughes, Australia; Todd 
Woodward, Canada; and a “Best Poster prize” awarded 
to Natasza Orlov and Paul Allen, United Kingdom, for 
their work on real-time fMRI neurofeedback to down-
regulate superior temporal gyrus activity);
• The continuum of experiences in the community and in 
different cultures (Philip Corlett, United States; Peter 
Moseley and Charles Fernyhough, United Kingdom; 
Sara Siddi and Antonio Preti, Italy);
• The relationship between hallucinations and other 
symptoms (Clara Humpston and David Linden, 
United Kingdom; Elizabeth Pienkos, Cherise Rosen 
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and Nev Jones, United States; Angela Woods, United 
Kingdom); and
• Subtypes of hallucination experiences (Craig 
Steel, United Kingdom; Daniel Collerton, United 
Kingdom; Prabitha Urwyler, Switzerland; Susan 
Rossell, Australia; Maya Schutte and Iris Sommer, the 
Netherlands).
The reports from 7 groups are presented here. Other pre-
sentations discussed collaborative projects in progress 
and new ideas for consideration in future meetings.
In the first article, Maijer et al4 present a summary of 
the issues that have dominated the field on hallucina-
tory experiences in children and adolescents since the 
last 2014 ICHR review on the topic.5 Notably, the study 
warns us to be careful about an overreliance on the sig-
nificance of terminology such as “persistence” given the 
varied trajectories of symptoms across psychotic, affec-
tive, anxiety, autistic and personality disorders, and the 
behavioral and functioning spectrum. Accumulating evi-
dence strongly links hallucinations in children and ado-
lescent with suicidality and flags the importance of social 
and cultural factors in modulating the initial appearance 
and appraisal of hallucinations. A review of therapeutic 
approaches for children and adolescent seeking help for 
hallucinations provides valuable insights into the role and 
evidence base of psychoeducation, psychotherapy, com-
munity services, and medications. Finally, some recom-
mendations about assessment measures and clinical and 
treatment approaches provide a useful framework (and a 
“stepwise guide” for clinicians) when encountering child-
ren and adolescents in clinical practice.
Luhrmann et al6 then explore the possibility of  mul-
tiple pathways to hallucinations. Trauma has featured 
most prominently in psychosis research in the past few 
years and it is a topic of  enormous clinical importance. 
Although the negative impact of  trauma can never be 
disputed or ruled out, the authors incline us toward cau-
tion in inferring an inherent link between trauma and 
hallucinations. They suggest that trauma sometimes 
plays a major role in hallucinations, sometimes a minor 
role, and sometimes no role at all. Using novel ethnogra-
phy evidence collected in Ghana’s “okomjo,” as well as 
qualitative and quantitative information, they describe 
patterns of  hallucinatory experiences that appear to 
vary as a function of  trauma input. Evidence presented 
in support includes the role of  imagery practice, focused 
attention, wilful training, and/or compartmentaliza-
tion, which act to form and shape hallucination-like 
experiences.
In the third article, Thomas et al7 discuss the applica-
tion of digital technologies such as computer software, 
the Internet, smartphones, wearable sensors, computer 
games, or virtual reality to the needs of people with 
hallucinatory experiences. They argue that the field of 
digital mental health is rapidly expanding with digital 
tools being used for the purpose of mental-health assess-
ment, intervention, and supporting self-help, but that the 
application of this digital technology to hallucinations 
is lagging. It is envisaged that digital tools will contrib-
ute to improved self-management and service provision 
for people experiencing hallucinations. Highlighted uses 
include smartphones to monitor and manage intermit-
tently occurring hallucinations, therapeutic applications 
of audio and video media such as virtual and augmented 
reality, specific exercises targeting verbal aspects of hal-
lucinations, and avatars to represent hallucinatory voices 
and to facilitate peer support. Challenges in the further 
development of digital tools include how to increase 
access, how to market resources to people who need it, 
identifying suitable funding schemes, and how to navi-
gate the opportunities and challenges brought about by 
big datasets.
Next, Siddi et al8 report on a large multicountry study 
that sought to address similarities and differences in 
hallucinatory-like experiences across cultures, stability 
of the continuum construct, invariance, and psychopath-
ological correlates (the E-CLECTIC study). The study 
enrolled 4419 participants across 10 countries to establish 
the validity, factor structure, and measurement invariance 
of the Launay–Slade Hallucinations Scale–Extended 
(LSHS-E). Network analyses between the LSHS-E and 
the 3 dimensions of the Community Assessment of 
Psychic Experiences (CAPE) were performed to assess 
convergent and divergent validity of the LSHS-E. Based 
on confirmatory factor analysis, the best fit was a 4-fac-
tor model, which proved invariant by country and clin-
ical status, pointing to cross-national stability of the 
hallucination-proneness construct. Among the different 
components of hallucination-proneness, auditory-visual 
hallucinatory experiences had the strongest association 
with the positive dimension of the CAPE (compared with 
the depression and negative dimensions). Finally, the 
LSHS-E’s intrusive and unwanted thoughts dimension 
was more prominently represented among people with a 
diagnosis of mental illness than in nonclinical individuals 
pointing to subtle differences between clinical and non-
clinical groups in symptom expression.
In a departure from previous years in which much 
work was devoted to characterizing hallucinations only, 
the next 2 reports attempt to characterize their relation-
ship to other symptoms. First, Humpston et al9 explore 
how computational psychiatry approaches can explain 
auditory verbal hallucinations and delusions. Instead of 
viewing phenomenology and neuroscientific approaches 
as opposed and essentially incompatible, the authors 
argue that these fields may be bridged through the use 
of modeling. Through a blending of computational 
mathematical models and phenomenological accounts, 
they explain how delusional thoughts and hallucinations 
can be viewed as intrinsically related. Although mod-
ern approaches have tended to view hallucinations and 
S3
Hallucination Research: Into the Future, and Beyond
delusions as separate and dichotomous phenomena, the 
authors argue that that they are both epiphenomena of a 
transformation in consciousness, different manifestations 
of similar neural processes, and that this framework can 
be explained through computational models. Through 
this theoretical lens, experiences such as auditory verbal 
hallucinations, agency deficits, and delusions of owner-
ship of thoughts may also be explained.
Pienkos et  al10 then explore the relationship between 
hallucinated voices and other phenomena including 
expressions of subjectivity with a view to expand our 
understanding of the phenomenological constellation to 
which hallucinations belong. They argue that the move 
away from traditional diagnostic categories toward a 
transdiagnostic approach has tended to isolate symptoms 
(like hallucinations) from related experiential states and 
obscure the complex and dynamic changes occurring 
simultaneously in other domains of experience. Their 
report contextualizes hallucinations within the realm of 
mental states associated with psychosis, with a focus on 
perception, selfhood and reality, temporality, interper-
sonal experience, and embodiment. The authors then 
discuss phenomenological and neurocognitive theories 
on “pre-reflective” processes involved in these changes, 
as well as the potential impact of trauma on these phe-
nomena. They suggested that future research should 
incorporate a broader range of experiential alterations, 
potentially expanding on traditional definitions of 
hallucinations.
The final report addresses some of the limitations 
in the assessment of symptoms in clinical population 
groups. Although clinical interventions that target mul-
tiple modalities of hallucinatory experiences are still in 
early stages of development, evidence is accumulating of 
the importance of assessing these experiences in a meth-
odologically valid way. Rossell et al11 present validation 
data for the Questionnaire for Psychotic experiences 
(QPE) that assess hallucinations in multiple modali-
ties. After receiving input from voice-hearers and ICHR 
members during scale development, the 50-item QPE was 
designed to assess the presence, severity, and phenome-
nology of hallucinations and delusions. Validation was 
conducted in 173 participants who fulfilled diagnostic 
criteria for schizophrenia, schizoaffective disorder, bipo-
lar affective disorder, major depressive disorder, and non-
clinical participants with psychotic experiences. Analyses 
showed good psychometric properties, consolidating 
an argument for the QPE to be used in transdiagnostic 
assessments.
Overall, these reports present several key and priority 
areas for hallucination research over the coming years. 
These also represent many challenges and opportunities 
that cannot be achieved without strong collaborative rela-
tionships between experts with different areas of exper-
tise, as well as genuine partnerships with people with 
lived experience who must be consulted about research 
which concerns them. The following open scientific 
meeting of the ICHR has just been held in Kyoto, 
Japan (October 2018), hosted by Dr Jun Miyata and Dr 
Michihoko Koeda, whereas the upcoming biennial ICHR 
meeting will take place in Durham, United Kingdom, 
in September 2019, hosted by Pr. Charles Fernyhough. 
Further details about the ICHR and future meetings are 
available from hallucinationconsortium.org.
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